Physician profile
Giulio Bianchi
NPI 1447244124
$994.82
in general payments reported to CMS, 2019-2025
12 companies · $13.50 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $243 · 2022: $24.34 · 2024: $97.78 · 2025: $13.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $438.24 | 2019-2025 | Airsupra |
| Amgen INC. | $126.92 | 2019-2020 | |
| Amarin Pharma, INC. | $96.44 | 2019-2020 | |
| Novo Nordisk INC | $82.76 | 2019-2024 | Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $80.96 | 2019-2020 | |
| Pfizer INC. | $50.13 | 2019-2020 | |
| Lilly USA, LLC | $37.60 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.34 | 2019-2020 | |
| Gilead Sciences, INC. | $15.00 | 2020 | |
| Merck Sharp & Dohme LLC | $14.81 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.63 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Giulio Bianchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.